Cell-penetrating peptides: 20 years later, where do we stand?

被引:670
|
作者
Bechara, Cherine [1 ]
Sagan, Sandrine [1 ]
机构
[1] Univ Paris 06, Lab BioMol, Cc 182, ENS,UMR CNRS 7203, F-75252 Paris 05, France
关键词
Endocytosis; Membrane translocation; Glycosaminoglycans clustering; Arginine; Tryptophan; ARGININE-RICH PEPTIDES; TAT-FUSION PROTEINS; PLASMA-MEMBRANE; LIPID-BILAYERS; ANTENNAPEDIA HOMEODOMAIN; ANTIMICROBIAL PEPTIDES; INTRACELLULAR DELIVERY; 3RD HELIX; ANTISENSE OLIGONUCLEOTIDES; INTERNALIZATION MECHANISMS;
D O I
10.1016/j.febslet.2013.04.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Twenty years ago, the discovery of peptides able to cross cellular membranes launched a novel field in molecular delivery based on these non-invasive vectors, most commonly called cell-penetrating peptides (CPPs) or protein transduction domains (PTDs). These peptides were shown to efficiently transport various biologically active molecules inside living cells, and thus are considered promising devices for medical and biotechnological developments. Moreover, CPPs emerged as potential tools to study the prime mechanisms of cellular entry across the plasma membrane. This review is dedicated to CPP fundamentals, with an emphasis on the molecular requirements and mechanism of their entry into eukaryotic cells. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1693 / 1702
页数:10
相关论文
共 50 条
  • [21] Cell dependent cell-penetrating peptides
    Shi, Junfeng
    Schneider, Joel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [22] Critical Race Theory 20 Years Later: Where Do We Go From Here?
    Howard, Tyrone C.
    Navarro, Oscar
    URBAN EDUCATION, 2016, 51 (03) : 253 - 273
  • [23] 30 YEARS OF PACEMAKER THERAPY - WHERE DO WE STAND
    STANGL, K
    WIRTZFELD, A
    ALT, E
    BLOMER, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1990, 79 (06): : 383 - 395
  • [24] DO CELL-PENETRATING PEPTIDES CROSS THE BLOOD-BRAIN BARRIER?
    Stalmans, S.
    Wynendaele, E.
    Bracke, N.
    De Spiegeleer, B.
    JOURNAL OF PEPTIDE SCIENCE, 2014, 20 : S211 - S212
  • [25] 50 years later. Where do we go?
    Fighera, Delfina Trinca
    REVISTA GEOGRAFICA VENEZOLANA, 2009, 50 (02): : 193 - 195
  • [27] Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics
    Heitz, Frederic
    Morris, May Catherine
    Divita, Gilles
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (02) : 195 - 206
  • [28] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382
  • [30] Where do we stand?
    Catt, Graham
    AUSTRALIAN VETERINARY JOURNAL, 2008, 86 (07) : N8 - N8